NC
IBB icon

North Capital’s iShares Biotechnology ETF IBB Stock Holding History

North Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-790
Closed -$114K – 366
2025
Q3 		$114K Buy
790
+1
+0.1% +$136 0.09% 136
2025
Q2 		$99.8K Hold
789
– – 0.09% 138
2025
Q1 		$101K Buy
+789
New +$107K 0.1% 134

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

North Capital's IBB Position: Q4 2025 in Review

North Capital sold out of iShares Biotechnology ETF (IBB) in Q4 2025, closing a stake of 790 shares — an estimated $114K sold.

North Capital first reported a position in IBB in Q1 2025 and held it in 3 quarters. The position peaked at $114K in Q3 2025. 958 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

  • North Capital reported no remaining iShares Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
  • North Capital sold 790 iShares Biotechnology ETF shares in Q4 2025, an estimated $114K.
  • North Capital first reported a position in iShares Biotechnology ETF in Q1 2025 and held it in 3 quarters.
  • North Capital's iShares Biotechnology ETF position peaked at $114K in Q3 2025.
  • 958 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on North Capital's 13F filing for Q4 2025, filed 18 Feb 2026.